Filter News
Area of Research
- Biology and Environment (14)
- Clean Energy (5)
- Computational Biology (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (2)
- Materials (4)
- Materials for Computing (1)
- National Security (4)
- Neutron Science (3)
- Quantum information Science (5)
- Supercomputing (37)
News Type
News Topics
- (-) High-Performance Computing (55)
- (-) Quantum Science (34)
- 3-D Printing/Advanced Manufacturing (58)
- Advanced Reactors (13)
- Artificial Intelligence (56)
- Big Data (30)
- Bioenergy (57)
- Biology (66)
- Biomedical (33)
- Biotechnology (11)
- Buildings (24)
- Chemical Sciences (36)
- Clean Water (14)
- Climate Change (57)
- Composites (12)
- Computer Science (102)
- Coronavirus (21)
- Critical Materials (4)
- Cybersecurity (20)
- Decarbonization (49)
- Education (1)
- Emergency (2)
- Energy Storage (44)
- Environment (118)
- Exascale Computing (28)
- Fossil Energy (4)
- Frontier (27)
- Fusion (39)
- Grid (28)
- Hydropower (5)
- Irradiation (1)
- Isotopes (35)
- ITER (3)
- Machine Learning (24)
- Materials (74)
- Materials Science (65)
- Mathematics (7)
- Mercury (7)
- Microelectronics (2)
- Microscopy (28)
- Molten Salt (2)
- Nanotechnology (28)
- National Security (46)
- Net Zero (9)
- Neutron Science (59)
- Nuclear Energy (68)
- Partnerships (23)
- Physics (35)
- Polymers (13)
- Quantum Computing (23)
- Renewable Energy (1)
- Security (14)
- Simulation (36)
- Software (1)
- Space Exploration (13)
- Statistics (1)
- Summit (32)
- Sustainable Energy (55)
- Transformational Challenge Reactor (4)
- Transportation (37)
Media Contacts
Neuromorphic devices — which emulate the decision-making processes of the human brain — show great promise for solving pressing scientific problems, but building physical systems to realize this potential presents researchers with a significant
The world is full of “huge, gnarly problems,” as ORNL research scientist and musician Melissa Allen-Dumas puts it — no matter what line of work you’re in. That was certainly the case when she would wrestle with a tough piece of music.
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
Carrie Eckert applies her skills as a synthetic biologist at ORNL to turn microorganisms into tiny factories that produce a variety of valuable fuels, chemicals and materials for the growing bioeconomy.
Research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2021 R&D 100 Awards, plus special recognition for a COVID-19-related project.
Of the $61 million recently announced by the U.S. Department of Energy for quantum information science studies, $17.5 million will fund research at DOE’s Oak Ridge National Laboratory. These projects will help build the foundation for the quantum internet, advance quantum entanglement capabilities — which involve sharing information through paired particles of light called photons — and develop next-generation quantum sensors.
An international problem like climate change needs solutions that cross boundaries, both on maps and among disciplines. Oak Ridge National Laboratory computational scientist Deeksha Rastogi embodies that approach.
Improved data, models and analyses from ORNL scientists and many other researchers in the latest global climate assessment report provide new levels of certainty about what the future holds for the planet
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.